Pharma Journalist

7th World CNS Summit
2019-02-19 - 2019-02-21 | Seaport Hotel & World Trade Center, One Seaport Lane, Boston, MA, 02210, United States
The 7th World CNS Summit is the only industry-specific conference exclusively focused on advancing translational neurodegenerative research.

World CNS’s mission is to reinvigorate drug discovery and development across multiple neurodegenerative disorders by providing an interactive environment that ensures thought-provoking discussions and unparalleled networking opportunities for all of our attendees, helping to overcome the translational challenges in developing efficacious therapeutics.
Developed in combination with experts from Biogen, Eisai, Merck, AbbVie and other leading organizations, the World CNS Summit uniquely combines distinct neurodegenerative diseases in one setting to examine mechanisms of disease and emerging strategies for targeting.
Following numerous neurodegenerative disease clinical failures, the neurodegenerative disease field requires a refreshed approach towards drug development to drive clinical success.
Now in its 7th successful year, the World CNS Summit challenges traditional thinking to guide drug development of efficacious treatments for neurodegeneration, bringing together over 150+ leading minds in the neurodegenerative space, from academia, pharma, biotech and leading consortia, to provide a unique opportunity to bridge the gap of translational drug development.
To learn more and to register online, visit http://bit.ly/2AfTc9J

Pharma Security Asia 2019
2019-02-19 - 2019-02-20 | Singapore, Singapore
The importance of the pharmaceutical industry in the modern-day Asian society cannot be overstressed especially as there are new diseases springing up from different areas, strengthening the importance of adequate drug research and development activities. However, with the growth of the industry in Asia comes the increase in fake drugs. In recent times, these products are still being produced and passed down to consumers in large quantities amidst the impact of the various counterfeiting hubs that have been seen to operate on a global scale. According to World Health Organization (WHO), about ten to thirty percent of the pharmaceuticals distributed to most third world countries are fake and this industry is growing at an alarming rate, even faster than legitimate pharmaceutical companies raking in about $217 billion yearly in sales.
We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.
Thus, To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Security Asia 2019 – An Anti-Counterfeiting, Drug Serialization and Supply-Chain Security Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
Social Media:
@corvusglobal
https://www.facebook.com/corvusglobalevents/
https://twitter.com/corvusglobal?lang=en

Outsourcing in Clinical Trials West Coast 2019
2019-02-12 - 2019-02-13 | Hyatt Regency San Francisco Airport Hotel 1333 Bayshore Highway Burlingame 94010
After record-breaking attendance in 2018, Arena International’s flagship Outsourcing in Clinical Trials West Coast conference returns to the Bay Area for its 11th year in February 2019.
With 6 tracks spanning across 2 days, the 2019 event is guaranteed to provide you with practical takeaways to help you accelerate your clinical trial timelines as well as insider knowledge on new innovations and technological advancements in the industry.
Focused on enabling collaboration between the clinical trials community in the Bay Area, the 2019 agenda is jam-packed with interactive sessions such as fireside chats, panel discussions, think-tanks and more. Whether you want to dive into a presentation on digital biomarkers or a panel discussion on measuring the health of your vendor partnerships, there is something for everyone at the upcoming meeting.
Don’t miss out on; join us in Burlingame on 12-13 February by registering your place today!

Outsourcing in Clinical Trials: Medical Devices Europe 2019
2019-02-06 - 2019-02-07 | Hilton Munich Airport Terminalstraße Mitte 20 85356
The 6th annual Outsourcing in Clinical Trials Media Devices Europe Conference returns yet again in 2019!
The event will bring together trial sponsors rom across Europe for 2 days, providing engaging presentations from the biggest names in the sector.
The 2019 programme will feature the latest industry trends and outsourcing challenges for the European medical device and diagnostics community. We’ll be exploring the latest regulatory challenges for medical device manufacturers and the opportunities for greater efficiency in trials.
We look forward to seeing you there!

13th Annual Parallel Trade Conference 2019
2019-02-05 - 2019-02-06 | Holiday Inn, Kensington Forum, 97 Cromwell Road, London, SW7 4DN, United Kingdom
SMi presents its 13th annual Parallel Trade conference, taking place in London on the 5th-6th of February 2019. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The 2019 event is particularly valuable since Brexit and the news of the UK officially leaving the EU on the 29th of March 2019. As such, the UK will no longer be part of the EU free market; hence, having a significant impact on parallel trade.
Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2019. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.

To learn more about this event, and to register online, visit www.parallel-trade.com/PharmaJ

3rd Annual CAR-T Congress EU
2019-01-30 - 2019-01-31 | Millennium Gloucester Hotel, 4-18 Harrington Gardens, Kensington, London, SW7 4LH, United Kingdom
CAR-T cell therapy has shown unparalleled success in haematological malignancies, paving the way for the field of immuno-oncology. In 2017 two therapies achieved FDA approval in the USA, and following recent approval by the EMA, it is a landmark time for the industry.

Despite the huge successes there are still a number of hurdles to overcome before CAR-T can be effective in mainstream oncology beyond haematological malignancies. The European CAR-T Congress’ mission is to address the opportunities and challenges that presently face the CAR-T field, to maximise the potential of this ground-breaking therapy.
Hear first-hand the story behind the successes of Novartis & Kite on their roads to approval. Discover how to improve manufacturing with automation to lower cost and increase the scope and reach of the therapies from innovators such as Torque Therapeutics. Explore the viability of allogeneic CAR-T with Cellectis, Celyad and Servier on their approaches to off-the-shelf products. Atillio Bondanza also shares strategies to improve safety with a better understanding of the underlying mechanisms of toxicity.
20+ industry leaders will be offering insight on:

Solid tumour targeting: overcoming the tumour microenvironment
Multi-specific & dual targeting CARs
Process development, scalability & automation
Allogeneic vs Autologous: the potential of off-the-shelf therapies
Patient access, implementation & regulatory challenges
Advances in gene engineering
Safety and toxicity

There is also a dedicated poster session, whereby attendees can showcase their latest research to the CAR-T community, deadline for submissions 14th December 2018.
Save up to £300 by booking on the early bird rate before Friday 30th November 2018. 2019 is going to be a big year for CAR-T in Europe, don’t be the one to miss out on the latest developments.
To learn more about this event, and to register online, visit www.car-tcongresseu.com

3rd Microbiome Movement – Drug Development Europe
2019-01-28 - 2019-01-30 | Novotel Paris Est, Paris, France
Recent breakthroughs in DNA sequencing, metagenomic analysis and computational techniques have given scientists new insight into the structure and function of the human microbiota, an interconnected community of symbiotic, commensal and pathogenic microorganisms. As valuable clinical data solidifies the importance of the human microbiome on human health and disease, recent efforts have sought to harness this research to create microbiome-based therapeutics.

Situated at the heart of therapeutic R&D, the Microbiome Movement – Drug Development Summit kick starts 2019, once again to help large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.
Set to tackle the greatest scientific, regulatory, clinical, manufacturing and commercialisation challenges across the entire drug development value chain, this meeting will showcase leading industry case studies focused on enhancing the application of novel technologies to standardise results, accelerate target discovery and optimise the translation of microbiome research into safe and effective therapeutic products.
View the complete programme here.

SMi’s 8th Annual Pharmaceutical Microbiology
2019-01-21 - 2019-01-22 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s 8th Annual Pharmaceutical Microbiology: Addressing the key challenges, trends and strategies in contamination control
Conference: 21st & 22nd January 2019
Workshop: 23rd January 2019
Location: Copthorne Tara Hotel, London, UK
Website: http://www.pharma-microbiology.com/PharmaJournWL
SPONSORED BY: GOLD SPONSOR: DuPont; SPONSORS: Mettler Toledo, Biomerieux and Copan Group
CHAIRED BY:
James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society
Olivier Chancel, Sterility and Aseptic Process Assurance, Expert, Boehringer Ingelheim

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding. In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022. This is the 8th year of a conference which is continually run by SMi and which has been very successful over the past few years.
Developing on last years’ success, Pharmaceutical Microbiology UK 2019 will bring together industry experts to discuss and analyse the latest advancement and challenges within pharmaceutical microbiology. Discover how you can keep up with regulatory changes and maintain the utmost efficiency during production and testing.
Event Hashtag: #PharmaMicro
At the 8th Annual Pharmaceutical Microbiology Conference, you will gain insight into:

Challenges in development of a contamination control strategy for different product types
A series of learning experiences within contamination from Boehringer Ingelheim
The use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control
Case studies in deinococcus and fungal and bacterial spores in cleanrooms
Influence of temperature of incubation on results of microbiological environmental monitoring
Risk mitigation strategies for animal-derived raw materials

FEATURED SPEAKERS INCLUDE:

Alexander Stoll, VP Competence Center Microbiology & Aseptic Technique Quality Management, Fresenius Kabi
Di Morris, Senior Manager, Team Leader, Vaccines Quality Audit, GSK
Marine Marius, Scientist, Analytical Research & Development Europe, Sanofi Pasteur
Philippe Dutot, Sterility Assurance Specialist, Novo Nordisk
Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
Thierry Bonnevay, Microbiology Platform Head, Analytical Research and Development, Sanofi Pasteur
Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

KEY TOPICS FOR 2018 INCLUDE:

Rapid Microbial Methods
Revision of Annex 1 and impact on pharmaceutical microbiology
Contamination control strategies and case studies
Mycoplasma detection, prevention and control
Future of endotoxin testing in pharmaceutical industries
Strengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent
Mold contamination control
Influence of temperature of incubation on results of microbiological environmental monitoring

WHO SHOULD ATTEND
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist
EARLY BIRD-RATES

BOOK BY 28TH SEPTEMBER AND SAVE £400
BOOK BY 31ST OCTOBER AND SAVE £200
BOOK BY 30TH NOVEMBER AND SAVE £100

To learn more about this event, and to register online, visit http://www.pharma-microbiology.com/PharmaJournWL

Social Media in the Pharmaceutical Industry
2019-01-21 - 2019-01-22 | Holiday Inn London – Kensington Forum
SMi Group are delighted to present the return of their 11th annual Social Media in the Pharmaceutical Industry conference to London on the 21st– 23rd January 2019.

Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and physicians. How the pharmaceutical industry utilize social media is particularly complex as regulators such as the FDA have not yet written the rules about how pharmaceuticals can engage with potential customers and patients.
Join SMi’s 11th annual Social Media in the Pharmaceutical Industry conference to learn the best way your company can benefit froma robust social media strategy. Hear from industry experts on how to leverage social media platforms by keeping the patient at the forefront and exploring the latest advances in digital application such as Artificial Intelligence, challenges and techniques in the field of ‘social pharma’.
How Will You Benefit?
Network and learn from leading professionals such as:

[CHAIR] – Jason Browning, Global Head of Digital Communications & Social Media, Novartis
[CHAIR] – Emma Sutcliffe, Director Patient Engagement and Innovation, NexGen Healthcare Communications
Roeland Van der Heiden, Digital Director, AstraZeneca
Lin Lei, Associate Director Digital Customer Engagement, Teva
Joao Bocas, CEO, DigitalSalutem
Paul Tunnah, CEO, PharmaPhorumMedia
Jacob D Flindt, Founder, pro
Alan Shaw, Director, Strategic Planet; Senior Lecturer: Digital Marketing, Northumbria University
Dennis Fink, Campaign Manager and Social Media Channel Expert, Qiagen
Stefania Alvino, Multichannel Manager, Daiichi Sankyo Co., Ltd.

2019 Featured Highlights:

Explore a result driven, value focused social media strategy in the pharmaceutical industry
Gain insight into procedures and practices required prior to the implementation of social listening
Discuss how to personalise the content relationships with AI
Understand the optimisation of disease awareness through social media channels
Learn how to use social networks and digital communication to engage HCPs
GDPR regulations and limitations to product advertisement (with case studies)
Pharmacovigilance in social media – specifically in adverse events reporting

Check out the brochure online: www.social-media-pharma.com/pj
Early-Bird Rates

REGISTER BY 29TH SEPTEMBER AND SAVE £400
REGISTER BY 31ST OCTOBER AND SAVE £200
REGISTER BY 30TH NOVEMBER AND SAVE £100

Pre-Filled Syringes & Injectable Drug Devices Europe
2019-01-16 - 2019-01-17 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London.

The conference will offer a deep insight into key areas within the field, such as: new technologies and overcoming their hurdles to implementation; connectivity for devices; updates on drug development and the impact on device developments and new regulatory guidelines. Our line-up of expert speakers will enable delegates to learn from market leaders on best practices to overcome common industry hurdles.
Join us in January 2019 to network, benchmark and learn about developments at the forefront of the Pre-Filled Syringes and Injectable Drug Devices industry.
Chairs for 2019:

James Mellman, Device Manager, Novartis
Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT

Featured Speakers:

Anil Busimi, Strategy and Innovation Global Product Manager, SCHOTT
Cedric Gysel, Staff Device Engineer, Janssen
Davide Mercadante, Sr Associate Quality Drug Devices, Biogen
Elise Legendre, Head of Late stage PFS Development, Sanofi
James Mellman, Device Manager, Novartis
Joan Malmstrom, Principal Scientist, Novo Nordisk
Justin Wright, Global Head of Innovation, Novartis
Maggie Reiff, Associate Device Engineer, Pfizer
Mathieu Rigollet, Senior PFS Engineer, Roche
Michael Becker, Design Engineer, Boehringer Ingelheim
Reinhard Scheller, Commercial ManagerCyclo Olefin Polymers – COP Europe, Zeon Europe GmbH
Shota Arakawa, Researcher, Mitsubishi Gas Chemical Company
Stephen Barat, Head of Pre-Clinical and Early Clinical Development, SCYNEXIS
Steve Chamberlain, Device Engineering Manager, GSK
Suraj Ramachandran, Director, Merck
Vikas Jaitely, Senior Manager Pharmaceutical Sciences & CMC Regulatory Intelligence, Merck

Key Highlights this January:

Engage and interact with like-minded individuals through 5+ hours of dedicated networking time, within the conference programme
Gain insight from fellow field experts through our interactive programme structure and our fantastic delegation with representation from all aspects of the industry, as well as cross-industry thought leaders and decision makers
Discover new technologies being developed to circumvent common industry hurdles and discuss ways in which to overcome the barriers of implementation
Hear case studies about the streamlining of injectable device development – from development to market
Interact with regulatory bodies in order to glean insight into the most recent revisions to regulation and the best ways to integrate them into business practices
Learn about current drug development programmes which will have an imminent impact on the PFS and Injectable devices sector and discuss the influence which drug development has on device development
Discuss patient centricity and the impact of human factors on design processes

View the full agenda online: www.pre-filled-syringes.com/PJ
EARLY-BIRD RATES:

BOOK BY 28TH SEPTEMBER AND SAVE £400
BOOK BY 31ST OCTOBER AND SAVE £200
BOOK BY 30TH NOVEMBER AND SAVE £100

Sponsored by: Mitsubishi Gas Chemical, HarroHoefliger, PHC Corporation, Zwick Testing Machines, Nemera, Schott, Zeon, Fruh ALPHABETICAL ORDER

Myanmar Lab Expo 2018
2018-12-14 - 2018-12-16 | Rose Garden Hotel, Yangon, Myanmar
The most definitive event for Laboratory Industry in Myanmar. Gathering the region’s hospital, Diagnostic, Laboratory, Analytical, Biotechnology and Scientific Instruments & Technology sectors in one convenient location and providing the perfect platform to discover the latest industry innovations, to network and do business.

Myanmar Phar-Med 2018
2018-12-14 - 2018-12-16 | Rose Garden Hotel, Yangon, Myanmar
This is the biggest trade fair for the medical industry in Myanmar, focused on hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors, providing the perfect platform to discover the latest industry innovations, to network and do business.

AI & Big Data for Pharma, part of DATAx
2018-12-12 - 2018-12-13 | New York Hilton Midtown
AI & Big Data for Pharma Summit 2018: Leverage Data Analytics to Deliver Patient-Centric Outcomes

With the race to adopt data and analytics, the pharma ecosystem is transforming to keep up with the rapid pace of change. Unprecedented volumes of real-time data are right at our fingertips, leaders must think strategically about how to gather, harvest, and leverage insights. The is the must-attend event to enhance AI and analytics capability in drug discovery and development, translate patient data into meaningful insights, and master the art of a seamless journey in pharma supply chain and logistics.
Topic Areas Covered Include:

Leveraging real time data in R&D and challenges of unstructured data
Accelerating drug discovery and development through advanced analytics
Streamlining clinical trial efficiency using AI and machine learning
Cultivating industry partnerships to build knowledge networks
The changing face of pharma and how the industry is evolving
Rise of the digital patient: Personalised patient care, precision medicine and AI
Managing demand forecasting, planning, and reduce waste in commercial analytics
Transparency in the global supply chain and optimising robotics and AI

Find out more information and register here: http://bit.ly/2O3MQ1Z

7th Lung Cancer Screening & Continuum of Care
2018-12-12 - 2018-12-13 | Tampa, FL, USA, FL, United States
ACI is excited to announce our 7th Lung Cancer Screening & Continuum of Care Conference on December 12-13, 2018. A dedicated forum to learn and network with representatives from organizations nationwide that are prepared to deliver superior service in thoracic oncology.
Our event will be an exploration of techniques and policy changes to better fit lung screening programs through case studies, research findings and organizational models from renowned healthcare and radiology institutions. The top thoracic oncology programs in the country will showcase their successes and share strategies in achieving excellence in patient care and cost-effective management.

This two-day event will focus on implementing lung screening programs and services to maximize competitive advantage, meet increased demand and exceed patient satisfaction. The goal of this event is to bring industry leaders together, highlight the best practice achievements, and discuss the current issues and developments in imaging services for the thoracic oncology community.
Lung cancer is the leading cause of cancer-related deaths in the United States. This largely stems from lung cancer’s minimal symptoms in its early stages, which is when the disease is most treatable. For this reason, there is a push for regions to offer screening services for their populations, enabling potential patients to receive care at the most opportune time. Providing this service to potential patients comes with its own challenges, such as motivating patients to get screened regularly, generating funding for these services, raising awareness in your community and many more.

Tumor Targeted Lymphocyte Summit
2018-12-11 - 2018-12-13 | The Colonnade Hotel, 120 Huntington Ave, Boston, MA, 02116, United States, United States
The Tumor Targeted Lymphocyte Summit is the first, dedicated meeting that unites the expert community working in TIL and CTL therapies to network, learn and determine strategies to enhance the efficacy of this adoptive cell therapy in solid tumors.

As CAR-T fails in the fight to deliver efficacy in solid tumors, the field is desperately exploring alternative adoptive cell therapies which are strong enough to rise to the challenge. TILs and CTLs have successfully been utilized in melanoma and now with patient demand growing, TIL-based therapies are fast becoming a more attractive approach to solid tumors.
Sounds interesting? Find out more – get free event brochure here: http://bit.ly/2zgKRSx

Antigen-Specific Immune Tolerance Europe Summit
2018-12-10 - 2018-12-12 | Park Plaza Victoria, 239 Vauxhall Bridge Road, London, SW1V 1EQ, United Kingdom
Optimizing the Discovery, Translation and Clinical Development of Safe and Effective Antigen-Specific Immune Tolerance Inducing Therapies to Treat Autoimmune Diseases.

The clinical heterogeneity of more than 80 autoimmune diseases presents a significant challenge with respect to the development of therapies designed to re-establish self-tolerance. As the first generation of antigen-specific immune tolerance therapies enters the clinic and excitement around the recent deals, partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to unite.
Tackling key R&D challenges, such as antigen identification, animal model predictability, translation and clinical design, the Antigen-Specific Immune Tolerance Europe Summit is the first European centric, dedicated platform that brings key decision makers together to successfully translate ground breaking science into a novel class of therapies to treat autoimmunity.
To learn more about this event, and to register online, visit http://www.as-immunetolerance-eu.com/

Cold Chain Distribution
2018-12-10 - 2018-12-11 | Copthorne Tara Hotel, Scarsdale Place, Kensington, United Kingdom
SMi proudly presents the 13th annual Cold Chain Distribution Conference and Exhibition, taking place at the Copthorne Tara Hotel in Kensington, London between the 10th – 11th December.

The 13th annual event will specifically focus on recent advances in temperature-controlled logistic solutions and the impact of regulatory changes on this multi-billion-dollar industry. The event will also address the impact of the overwhelming digitalisation of the industry and how companies, from biotech’s to pharma, need to adapt, as well as the crucial challenges of supply chain visibility and data integrity in the cold chain industry.
The two-day event will also look at various developments within the industry, guiding companies on how best to ensure costs are kept low, and quality remains high, whilst simultaneously staying compliant to global regulations.
This year’s event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations and issues in the field of temperature-controlled distribution.
Chairs for 2018:

Bob Hayes, Director, SeerPharma (UK)
Tony Wright, CEO, Exelsius

Featured Speakers:

Bob Hayes, Director, SeerPharma (UK)
Stephen Mitchell, Quality Lead Logistics Partnerships, GSK
GianneOlaes-Dénis, Supply Chain Quality Manager, SanofiGenzymeEurope
Stefan Braun, Managing Director, SmartCAE
GianpieroLorusso, Director, Supply Operations and GS, Merck
Francicso Rizzuto, Cargo Specialist, Manager for Europe, IATA
Marco Gaudesi, Pharmacist – GDP and Cold Chain Referent, MSF
Henk Mulder, Head, Digital Cargo, IATA

Key Highlights this December:

Evaluate the current GDP guidelines, with reference to the recently published PQG/ECA guide and discover the implications for everyday practice
Explore the overwhelming digitalisation of the supply chain and identify the subsequent security issues involved
Discover the temperature-controlled logistic solutions to best optimize your supply chain
Discuss the technical agreements within the supply chain and find out what questions you should be asking
Identify the challenges for the supply chain within emerging markets and discover the best solutions for optimization of your process

View the full agenda online: www.coldchain-distribution.com/pj
EARLY-BIRD RATES:

BOOK BY 29TH JUNE AND SAVE £400
BOOK BY 28TH SEPTEMBER AND SAVE £300
BOOK BY 31ST OCTOBER AND SAVE £100

To learn more about SMi’s Cold Chain Distribution, and to register online, visit www.coldchain-distribution.com/pj

The Digital Pathology Congress
2018-12-06 - 2018-12-07 | London Heathrow Marriott Hotel, London, UK
The congress will have expanded coverage of new areas such as AI and computational pathology alongside the latest case studies and applications. To complement the latest scientific presentations, the conference will comprise of a vibrant exhibition room full of technology providers showcasing their technologies and other solutions; networking breaks allowing interaction with your peers; poster presentation sessions; and incisive Q&A panel discussions. Whether looking to hear more about the adoption and integration of digital pathology; seeking collaborations and tools to increase workflow; or uncover the latest developments in automated image analysis; the Congress is one not to be missed!
To learn more about this event, and to register online, visit https://goo.gl/42HTeh

BioFIT
2018-12-04 - 2018-12-05 | Lille Grand Palais 1 boulevard des Cités Unies 59000 Lille, FRANCE, France
EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT
With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
WHY ATTEND BIOFIT?
Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:

35% of collaborative research projects
30% of licensing deals
15% of equity investment deals
20% of services deals

Estimate based on the measurement of 2015 and 2016 delegates’ outcomes
KEY FIGURES:

1,200+ delegates
800+ organisations
35+ countries represented
1,000 deals generated in 2017

INSIDE THE EVENT:

A business convention with pre-qualified one-to-one meetings (partneringONE platform from EBD Group)
Identification of would-be CEOs
Conferences and roundtable discussions
Oral presentations of start-ups and licensing opportunities stemming from academia
An exhibition area
Informal networking evenings

Website: www.biofit-event.com
Twitter: @BIOFIT_EVENT
Contact:
Margaux Satola
Business Development Manager
msatola@eurasante.com
+33 (0)3 59 39 01 82

CBI’s Clinical Trial Agreement Series
2018-12-04 - 2018-12-06 | Wyndham Philadelphia Historic District, 400 Arch Street, Philadelphia, PA, 19106, United States
Designed to maximize your time out of the office, CBI’s three-day Clinical Trial Agreement conference series allows your team to select the content that best meets your business objectives. Attend your preferred event or BOTH for maximum value, learning and benchmarking. The Clinical Trial Legal and Contracting Forum, taking place December 4-5 in Philadelphia, serves as the only meeting that is singularly focused on the detailed legal and contracting issues that relate to clinical agreements of all types. The Clinical Trial Financial Management summit, taking place December 5-6 in Philadelphia, is designed to arm sponsors, CROs, AMCs and sites with the insights they need to develop, negotiated and manage the financial aspects of clinical trial agreements.
To learn more about this event, visit www.cbinet.com/ctafinance

Skin Microbiome Asia
2018-12-04 - 2018-12-05 | Hong Kong, Venue TBC
Skin Microbiome Asia | 4-5 December 2018 | Hong Kong – As K-Beauty and J-Beauty continue to storm the world, beauty start-ups are also emerging from Australia, India and across Southeast Asia. China, Singapore and Hong Kong remain mecca markets for international companies launching products into the region. There has never been a better time for cosmetics professionals to meet in Asia.

150+ industry experts will be gathering in Hong Kong this December to learn about the science behind the products from companies like Unilever, Cosmax, Mother Dirt and more.
Join multinationals, independent beauty brands, sequencing companies, regulators, pharma & biotech companies and academia to build your network throughout Asia Pacific.
Interested to learn more? Take a look at our agenda here: http://bit.ly/SkinAsiaAgenda
Or take advantage of our Super Early Bird Pricing and book your pass here: http://bit.ly/SkinAsiaRegistration
Praise for the event:
“An incredible event… Fast paced and full of new and relevant information from a variety of perspectives, each of which provide a complete and extensive snapshot of the industry and the future of microbiome friendly products” – TrūAura Beauty
“The value of this conference was absolutely unparalleled! I not only saw many old friends, collaborators and partners, but also met many new ones as well.” – ProdermIQ
To learn more about Skin Microbiome Asia, and to register online, visit www.skinmicrobiomecongressasia.com

4th Annual Oncolytic Virotherapy Summit
2018-12-04 - 2018-12-06 | Hilton Boston Back Bay Hotel, 40 Dalton St, Boston, MA, 02115, United States
The 4th Oncolytic Virotherapy Summit is dedicated to improving the commercial success of oncolytic viruses, in stand-alone and combination therapies.

As many oncolytic viruses progress through the clinical pipelines, drug developers need to ensure that their therapies are safe, efficacious and commercially viable. Make sure you stay ahead of the game and join Oncolytic Virotherapy Summit, where you will have an opportunity to pick the brains of 100+ senior industry peers and tackle your challenges in discovery, clinical development, manufacturing and regulations of oncolytic virotherapy.
This year we will be incorporating commercial insights from companies such as Merck, Virogen, Sagetis, Lokon Pharma, Replimmune, Western Oncolytics, DNAtrix and many more, which will allow you to learn from their case studies and improve your development strategies. Participate in the interactive roundtable and workshops to build strategies that maximise success in the clinic and commercially.
Sounds interesting? Find out more – get free event brochure here: http://bit.ly/2KzCLIh

ICI Europe Summit 2018
2018-11-27 - 2018-11-29 | The Sofitel Berlin Kurfuerstendamm, Augsburger Strasse 41, Berlin, 10789, Germany
ICI Europe Summit 2018 | 27-29 November 2018 | The Sofitel Berlin Kurfuerstendamm, Berlin
Evidencing How Checkpoint Combinations Can Enhance Every Stage of the Cancer Immunity Cycle
Rather than covering a random selection of immuno-oncology combinations, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle, enhancing the long-term success of immuno-oncology drug development.

Cutting through the noise and hype around the immuno-oncology field, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches.
Don’t miss this opportunity to join Merck, Genentech, AstraZeneca, Bayer, Roche and many other leading organisations, to empower you to make the right decisions with your IO pipeline and lay the foundations for your future success.
Access the complete programme to find out more about the speakers and what they will discuss: https://bit.ly/2Rr4TSI
Pharma Journalist readers are eligible for 10% discount to attend. Book online quoting VIP Code 9710PJ and you’ll automatically receive the discount. Applies to new bookings only. Cannot be used in conjunction with other offers. T&Cs apply.

The 4BIO Summit: Europe
2018-11-27 - 2018-11-28 | Rotterdam, Netherlands (venue TBC)
4Bio Europe will feature the most cutting-edge research and technology developments in the fields of qPCR/dPCR, NGS, microfluidics and gene editing. Scientific advancements coupled with cost reductions in these four areas of research have contributed to the improved diagnosis, monitoring, and treatment of disease.
With similar and shared methods and applications across the four main themes of the meeting, 4Bio Europe will provide a multi-disciplinary forum in which to discover crossover in your research, attend the latest cutting-edge talks that appeal to you mostand network with your peers and discover solutions to the whole spectrum of your research all in one location.
To learn more about this event, and to register online, visit https://goo.gl/Vza4PY

17th Pharmacovigilance 2018
2018-11-15 | Kohinoor Continental Hotel, Andheri Kurla Road, Andheri ( E ), Mumbai – India, Mumbai, 400059, India
17th Pharmacovigilance 2018
15th November 2018, Kohinoor Continental Hotel, Mumbai, India
17th Pharmacovigilance 2018 focuses on the advancements in Pharmacovigilance, Risk Management, and Drug Safety. IT emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.
SPONSORS:

Principal Sponsor: Apcer Life Sciences
Gold Sponsor: Syneos Health
Exhibitors: Ab Cube, Medvigil, Elsevier

KEY SPEAKERS:
DDC(I), CDSCO (HQ), Indian Drug Manufacturers’ Association (IDMA), FDA Maharashtra Lupin , Abbott, Merck Sharp & Dohme, Novartis , Abbott, AstraZeneca, Piramal, Reliance Life Sciences, GSK, Mylan Laboratories, Nishith Desai Associates, , Roche Pharmaceuticals, CliniSearch, GSK, Member Editorial Board Journal of Generic Medicines, England, Veeda Clinical Research, AWINSA Life Sciences,
CONFERENCE REGISTRATION:
In order to register you can simply Email: kavitha@virtueinsight.co.in or Tel: +91 44 24762472

Early Bird Discounted Price (Ends 12th October 2018 ) – 1 Delegate Pass – (INR 10,000 + GST (18%) per delegate)
Standard Price (13th October 2018 Onwards) – 1 Delegates – (INR 15,000 + GST (18%) per delegate)
Conference Sponsor, Exhibition Stall (Booth) and a paid Speaker slots are also available. We also have some sponsorship opportunities available for the event, which gives you an opportunity to speak/exhibit, and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

Get more from the event, with a broader scope bringing the whole communications value chain together.

Marketing and Customer Experience USA
2018-11-14 - 2018-11-15 | Sofitel Philadelphia Hotel, 120 South 17Th Street, Philadelphia, PA, 19103, United States
Redefine your customer relationships to become a valued healthcare partner
eyeforpharma’s Marketing and Customer Experience USA (November 14-15 2018, Philadelphia) breaks down the model you need to raise the bar on customer experience and get ROI on marketing strategies.

Digital is dead. Theoretical discussions about the power of technology are obsolete. But pharma has the potential to transform its customer relationships given the right tools.
eyeforpharma is bringing a practical guide to pharma marketers – a first of its kind event that will bring together all stakeholders and deliver a roadmap to revitalizing customer relationships. Go beyond theoretical discussions around digital innovation and discover how you can transform customer engagement with technology – and most importantly how to future-proof your business model and culture.

Go beyond conventional digital: Harness innovations that solves patient and physician problems to increase your product’s value proposition and rebuild your reputation
Exceed customer expectations, dominate the market
Ensure the latest guidance and inspiration is always available for a generation that expects on-demand access to information – and become the go-to source for your customers
Big data, big deal: refine analytics for deeper insights that put you on top
Don’t shout louder, find smarter insights to form a deeper understanding of customer needs for differentiated, targeted content
Secure workforce buy-in and customer backing will follow
Invest in your people with first-rate training and create a culture that will make your workforce want to shout about your products, so your employees become your best advocates

With the latest case studies, panels led by customers and out of industry expert sessions that will help you create the ultimate, effortless customer experience– this is the event to ensure your business is ready to dominate the market.
Some of the job roles and functions attending will be Digital, Customer Experience, Centers of Excellence, Innovation Strategists, Sales & Marketing Executives, Patient Engagement, IT leadership, Brand Managers, MCM and Innovation Heads.
To learn more about this event, and to register online, visit http://bit.ly/2LIaO1K

3rd Skin Microbiome Congress
2018-11-14 - 2018-11-15 | ILEC Conference Centre and Ibis London Earls Court, 47 Lillie Road, London, SW6 1UD, United Kingdom
3rd Skin Microbiome Congress | 14-15 NOVEMBER, 2018 | LONDON, UNITED KINGDOM
The average consumer uses up to 515 synthetic chemicals daily to eradicate dermalogical concerns – how can this be good for skin? Introducing the first European Skin Microbiome Congress.

Following the success of the inaugural Skin Microbiome Congress in Boston in May and our second congress in San Francisco in September, don’t miss the opportunity to join 200+ industry experts from multinational pharmaceutical, beauty and personal care companies, independent skincare brands and innovative biotechs to discuss the emerging relationship between the skin microbiome and healthy skin.
Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of:
Effective Networking – Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler application
Cutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome
Consumer Trends – Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome
Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics
Competitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products
Regulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product
With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don’t miss your chance to understand the next generation of natural skincare products!
To learn more about 3rd Skin Microbiome Congress, and to register online, visit www.skinmicrobiomecongresseu.com
CONTACT:
+44 (0)20 3696 2920
events@kisacoresearch.com

Biosimilars USA
2018-11-14 - 2018-11-15 | RENAISSANCE WOODBRIDGE HOTEL, NEW JERSEY, United States
Building on the success of previous events, SMi proudly announces the return of its 5th Annual Biosimilars USA Conference, taking place in New Jersey, USA on the 14th and 15th November 2018 and chaired by Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA.

The event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S.
Fresh from the press: On March 7th, 2018, the U.S.-FDA’s Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval.
Hear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.
This event is CPD accredited.
#SMiBioSimUSA
PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS
Tuesday 25th September 2018, Copthorne Tara Hotel, Central London, UK
08.30 – 12.30
Workshop A: Decoding how Stakeholders may Drive Biosimilar Adoption
Workshop Leaders: Tucker Herbert, Manager, ZS Associates
Christina Corridon, Associate Principal, ZS Associates
13.30 – 17.00
Workshop B: Dealing with Life Sciences Patents at the PTAB
Workshop Leaders: Ha Kung Wong, Partner, New York, Fitzpatrick, Cella, Harpper & Scinto
John Kirkland, Director, Intellectual Property, Alkermes, Inc.
WHO SHOULD ATTEND
Medical Directors, Scientific Directors, VP’s, Directors, Managers, Team Leaders, Partners, Consultants and Attorneys of:
Biosimilars, Biobetters, Biopharmaceuticals, Biostatistics, Business Alliances, Business Development, Clinical Operations, Commercial, Decision Analytics, Global Intelligence, Global Operations, Managed Markets and Trade Relations, Market assess, Marketing, Patient & Physician Services, R&D Policy, Regulatory Affairs, Scientific Affairs, and anyone else who works within the biosimilars industry!
EARLY BIRD-RATES
BOOK BY JUNE 29TH AND SAVE US$300
BOOK BY SEPTEMBER 28TH AND SAVE US$100
To learn more about Biosimilars USA, and to register online, visit www.biosimilars-usa.com/pharmajournalist

World ADC San Diego
2018-11-12 - 2018-11-15 | Marriott Marquis San Diego, 333 W Harbor Dr, San Diego, CA, 92101, United States
9th Annual World ADC San Diego 2018 | 12-15 November, 2018 | Marriott Marquis & Marina, San Diego, CA
Maximizing the clinical therapeutic window of antibody-drug conjugates is a challenge we’re continuing the grapple with.
As such, there is a lot to be shared and discussed at this year’s 9th Annual World ADC San Diego.

Since it’s conception in 2009 World ADC has risen to become the world’s leading and most comprehensive ADC meeting. The pinnacle event for thought-leading ADC drug developers.
Offering you an unparalleled learning and networking experience this year’s conference will share the very latest research advances, enabling you to maximize the clinical therapeutic window of your ADC candidate.
Join over 650 drug developers across 220 organizations from the likes of Daiichi Sankyo,Genentech, Bristol Myers Squibb, Immunomedics, Immunogen, Formation Biologics, FDA and Sutro Biopharma to:

Hear unpublished data for the first time during the new Late Breaking Abstracts session

Access superior breadth of ADC research across 4 streams of parallel learning across discovery, development, clinical and manufacturing

Communicate your new results, benchmark against your peers and gain invaluable feedback from the scientific community during the Poster Session

Gain tangible actions from discussing your challenges in one of the thirteen discussion led workshops

Recognise your peer’s achievements and maybe yours?during the 5th Annual World ADC Awards ceremony

Find out more https://info.hansonwade.com/worldadcsandiego
Download Full Agenda https://info.hansonwade.com/worldadcguide

Superbugs & Superdrugs USA
2018-11-12 - 2018-11-13 | Renaissance Woodbridge Hotel, 515 US Highway 1 South, Iselin, NJ, United States
Antimicrobial resistance, leading to the development of superbugs, is a major threat to public health and continues to increase as a problem, due to continued misuse of antibiotics. With pharmaceutical companies showing less focus on the development of new antibiotics, several incentive initiatives have been set up – CARBX, BARDA, IMI (EU) – in order to encourage reinvestments.

To address the ever-growing need of informative and thought-provoking discussions, Superbugs & Superdrugs USA conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers, within the field.
This years’ Superbugs & Superdrugs USA conference programme will help participants to learn about pathogen focused drug development; discover the best methods to overcome bacterial resistance through novel modes of action; discuss the state of developments within the antifungal space; develop an understanding of funding opportunities which support antibacterial research and development; gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used within the field, making this event the perfect platform to strengthen knowledge in key principles.
Speakers include:

Anthony Simon Lynch, Senior Scientific Director, Janssen
William Weiss, Director, Pre-Clinical Services, UNT Health Science Center
Tina Guina, Program Officer, Drug Development Section, NIAID/NIH
Mark Albrecht, Project Officer, HHS/ASPR/BARDA
Antonio DiGiandomenico, Principal Scientist, MedImmune
Andrew Tomaras, VP & Director of Microbiology, Bacterioscan
Dan Pevear, Sr Vice President & Director of Microbiology, VenatoRx
Ian Friedland, Clinical Consultant, ex-CMO, Achaogen

Plus, topical workshops on November 14:

Rapid diagnostics for drug resistance: Are we there yet?
Avoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics

Further details at http://www.superbugs-usa.com/PJWL
Twitter – @SMIpharm & #smibugs
LinkedIn – SMi Pharma
